|Outstanding Clinical Care|
|World Class Research|
|Exceptional Education & Training Programs|
Our mission is simple:
To reduce the burden of cancer in Georgia and across the globe.
What areas of the GRU Cancer Center programs have the most potential?
The major investments the university and its health system have made in cancer in
recent years make it fertile ground to produce the next big advancement in cancer
research and clinical care.
The Cancer Center’s patients-first model is built on a foundation of teamwork and synergy between the research and clinical facilities.
The GRU Cancer Center, which is working toward NCI designation, includes a 167,000-square-foot research building, which opened in 2006, and a clinical facility that opened in 2010. Together they provide state-of-the-art research and treatment, including several first-in-human protocols.
Effective Jan. 31, 2012, Dr. Samir N. Khleif was recruited from the National Institutes of Health, where he served as Chief of the National Cancer Institute’s Cancer Vaccine Section. Now as Director of the GRU Cancer Center, Dr. Khleif oversees all aspects of the enterprise’s cancer clinical care and research.